Published in Nature on May 26, 2011
Malaria medicines: a glass half full? Nat Rev Drug Discov (2015) 2.53
The evolutionary consequences of blood-stage vaccination on the rodent malaria Plasmodium chabaudi. PLoS Biol (2012) 1.61
The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons. Immunity (2016) 1.50
Engineering synthetic vaccines using cues from natural immunity. Nat Mater (2013) 1.48
Merck Ad5/HIV induces broad innate immune activation that predicts CD8⁺ T-cell responses but is attenuated by preexisting Ad5 immunity. Proc Natl Acad Sci U S A (2012) 1.46
Ontogeny of early life immunity. Trends Immunol (2014) 1.35
Induction of strain-transcending antibodies against Group A PfEMP1 surface antigens from virulent malaria parasites. PLoS Pathog (2012) 1.35
Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults. Am J Respir Crit Care Med (2013) 1.31
Adjuvants for human vaccines. Curr Opin Immunol (2012) 1.25
Schistosomiasis vaccines. Hum Vaccin (2011) 1.23
Designing tomorrow's vaccines. N Engl J Med (2013) 1.21
The future of human DNA vaccines. J Biotechnol (2012) 1.18
Systems vaccinology: probing humanity's diverse immune systems with vaccines. Proc Natl Acad Sci U S A (2014) 1.16
Unexpected fold in the circumsporozoite protein target of malaria vaccines. Proc Natl Acad Sci U S A (2012) 1.14
Immune activation alters cellular and humoral responses to yellow fever 17D vaccine. J Clin Invest (2014) 1.12
Synthetic Nanoparticles for Vaccines and Immunotherapy. Chem Rev (2015) 1.10
Vaccines, new opportunities for a new society. Proc Natl Acad Sci U S A (2014) 1.06
Bridging the gap: need for a data repository to support vaccine prioritization efforts. Vaccine (2015) 1.06
Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine. PLoS One (2012) 1.04
Systems vaccinology: its promise and challenge for HIV vaccine development. Curr Opin HIV AIDS (2012) 1.01
Systems biological approaches to measure and understand vaccine immunity in humans. Semin Immunol (2013) 0.98
Antigen dose and humoral immune response correspond with protection for inactivated infectious pancreatic necrosis virus vaccines in Atlantic salmon (Salmo salar L). Vet Res (2013) 0.98
Circulating Th1-Cell-type Tfh Cells that Exhibit Impaired B Cell Help Are Preferentially Activated during Acute Malaria in Children. Cell Rep (2015) 0.98
Modulating antibacterial immunity via bacterial membrane-coated nanoparticles. Nano Lett (2015) 0.97
Recent advances towards tuberculosis control: vaccines and biomarkers. J Intern Med (2014) 0.97
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination. Proc Natl Acad Sci U S A (2013) 0.94
The contribution of vaccination to global health: past, present and future. Philos Trans R Soc Lond B Biol Sci (2014) 0.93
Prime-boost approaches to tuberculosis vaccine development. Expert Rev Vaccines (2012) 0.91
Identifying gnostic predictors of the vaccine response. Curr Opin Immunol (2012) 0.89
Systems-level analysis of innate immunity. Annu Rev Immunol (2014) 0.88
Profiling immunity to HIV vaccines with systems biology. Curr Opin HIV AIDS (2012) 0.88
Systems immunology of human malaria. Trends Parasitol (2012) 0.86
Systems biology of natural simian immunodeficiency virus infections. Curr Opin HIV AIDS (2012) 0.85
Vaccine design: emerging concepts and renewed optimism. Curr Opin Biotechnol (2013) 0.84
Immunotherapy in prostate cancer: emerging strategies against a formidable foe. Vaccine (2011) 0.84
Self-delivery multifunctional anti-HIV hydrogels for sustained release. Adv Healthc Mater (2013) 0.83
Vaccination: the present and the future. Yale J Biol Med (2011) 0.83
Multiple vaccinations: friend or foe. Cancer J (2011) 0.83
Protection against SHIV-KB9 infection by combining rDNA and rFPV vaccines based on HIV multiepitope and p24 protein in Chinese rhesus macaques. Clin Dev Immunol (2012) 0.82
Systems immunogenetics of vaccines. Semin Immunol (2013) 0.82
Paediatric HIV infection in the 'omics era: defining transcriptional signatures of viral control and vaccine responses. J Virus Erad (2015) 0.79
Molecular and genetic inflammation networks in major human diseases. Mol Biosyst (2016) 0.79
Coping with genetic diversity: the contribution of pathogen and human genomics to modern vaccinology. Braz J Med Biol Res (2011) 0.79
Post-Genomics and Vaccine Improvement for Leishmania. Front Microbiol (2016) 0.78
Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies. Protein Cell (2015) 0.78
Pediatric Vaccine Adjuvants: Components of the Modern Vaccinologist's Toolbox. Pediatr Infect Dis J (2015) 0.78
Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection. Front Cell Infect Microbiol (2016) 0.77
Epidemiological determinants of successful vaccine development. Int J Med Sci (2013) 0.77
A derived network-based interferon-related signature of human macrophages responding to Mycobacterium tuberculosis. Biomed Res Int (2014) 0.76
TB Vaccines: The (Human) Challenge Ahead. Mycobact Dis (2014) 0.76
Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes. Infect Immun (2015) 0.76
Deconvolving heterogeneity in the CD8+ T-cell response to HIV. Curr Opin HIV AIDS (2012) 0.75
Cell-based gene therapy against HIV. Gene Ther (2015) 0.75
Transcription factor Batf3 is important for development of CD8(+) T-cell response against a phagosomal bacterium regardless of the location of antigen. Immunol Cell Biol (2015) 0.75
TIM-3, a Possible Target for Immunotherapy in Cancer and Chronic Viral Infections. Austin Virol Retro Virol (2014) 0.75
Impact of host genetic polymorphisms on vaccine induced antibody response. Hum Vaccin Immunother (2016) 0.75
Plasmodium knowlesi as a Threat to Global Public Health. Korean J Parasitol (2015) 0.75
Microbiome Changes during Tuberculosis and Antituberculous Therapy. Clin Microbiol Rev (2016) 0.75
Translating genomics research into control of tuberculosis: lessons learned and future prospects. Genome Biol (2014) 0.75
The prevention and eradication of smallpox: a commentary on Sloane (1755) 'An account of inoculation'. Philos Trans R Soc Lond B Biol Sci (2015) 0.75
Biomimetic and synthetic interfaces to tune immune responses. Biointerphases (2015) 0.75
Towards developing a vaccine for rheumatic heart disease. Glob Cardiol Sci Pract (2017) 0.75
TEMPORARY REMOVAL: Synthetic nanovaccines for immunotherapy. J Control Release (2017) 0.75
Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol (2006) 9.64
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature (2004) 9.40
Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature (2006) 6.28
Systems biology of vaccination for seasonal influenza in humans. Nat Immunol (2011) 6.09
Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol (2010) 6.05
Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci U S A (2010) 5.59
Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol (2003) 5.18
Integration with the human genome of peptide sequences obtained by high-throughput mass spectrometry. Genome Biol (2004) 4.91
Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science (2003) 4.80
The evolution of vertebrate Toll-like receptors. Proc Natl Acad Sci U S A (2005) 4.42
Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med (2008) 4.16
Caspase-11 protects against bacteria that escape the vacuole. Science (2013) 4.01
Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals. Nat Immunol (2009) 3.60
Caspase-1-induced pyroptotic cell death. Immunol Rev (2011) 3.47
Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci U S A (2005) 3.35
A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med (2003) 3.30
Uncovering a macrophage transcriptional program by integrating evidence from motif scanning and expression dynamics. PLoS Comput Biol (2008) 3.02
Pseudomonas aeruginosa activates caspase 1 through Ipaf. Proc Natl Acad Sci U S A (2008) 2.99
Multiple Nod-like receptors activate caspase 1 during Listeria monocytogenes infection. J Immunol (2008) 2.87
The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J Immunol (2003) 2.73
Cross-interference of RLR and TLR signaling pathways modulates antibacterial T cell responses. Nat Immunol (2012) 2.72
A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol (2007) 2.71
The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci U S A (2006) 2.63
Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion. Cell Host Microbe (2010) 2.49
TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J Exp Med (2006) 2.44
Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo. Immunity (2009) 2.44
TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system. Semin Immunopathol (2007) 2.42
Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus Type 2 infection. J Infect Dis (2007) 2.33
Memory T cell RNA rearrangement programmed by heterogeneous nuclear ribonucleoprotein hnRNPLL. Immunity (2008) 2.13
Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol (2003) 2.02
Systems biology of innate immunity. Immunol Rev (2009) 1.87
Cutting edge: Cytosolic bacterial DNA activates the inflammasome via Aim2. J Immunol (2010) 1.77
Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation. Cell (2013) 1.69
Transcription factor expression in lipopolysaccharide-activated peripheral-blood-derived mononuclear cells. Proc Natl Acad Sci U S A (2007) 1.63
Serpin 2a is induced in activated macrophages and conjugates to a ubiquitin homolog. J Immunol (2002) 1.60
Leishmania promotes its own virulence by inducing expression of the host immune inhibitory ligand CD200. Cell Host Microbe (2011) 1.59
Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection. J Immunol (2007) 1.57
A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin. J Exp Med (2007) 1.51
Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One (2009) 1.49
Merck Ad5/HIV induces broad innate immune activation that predicts CD8⁺ T-cell responses but is attenuated by preexisting Ad5 immunity. Proc Natl Acad Sci U S A (2012) 1.46
A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses. Nature (2012) 1.44
Identification of tuberculosis susceptibility genes with human macrophage gene expression profiles. PLoS Pathog (2008) 1.41
Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS (2007) 1.39
Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease. Proc Natl Acad Sci U S A (2005) 1.39
Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy. J Infect Dis (2008) 1.34
Myeloid differentiation primary response gene (88)- and toll-like receptor 2-deficient mice are susceptible to infection with aerosolized Legionella pneumophila. J Infect Dis (2006) 1.34
Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production. J Immunol (2007) 1.29
Altered inflammatory responses in TLR5-deficient mice infected with Legionella pneumophila. J Immunol (2007) 1.28
Generation of diversity in the innate immune system: macrophage heterogeneity arises from gene-autonomous transcriptional probability of individual inducible genes. J Immunol (2002) 1.28
The NLRP3 inflammasome detects encephalomyocarditis virus and vesicular stomatitis virus infection. J Virol (2011) 1.27
ATF3, an adaptive-response gene, enhances TGF{beta} signaling and cancer-initiating cell features in breast cancer cells. J Cell Sci (2010) 1.23
Genome-wide histone acetylation data improve prediction of mammalian transcription factor binding sites. Bioinformatics (2010) 1.22
A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus erythematosus. Proc Natl Acad Sci U S A (2005) 1.21
CD4+ T cells and toll-like receptors recognize Salmonella antigens expressed in bacterial surface organelles. Infect Immun (2005) 1.20
Bright field microscopy as an alternative to whole cell fluorescence in automated analysis of macrophage images. PLoS One (2009) 1.19
Activating transcription factor 3 is a negative regulator of allergic pulmonary inflammation. J Exp Med (2008) 1.18
ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol-induced lipid body formation. J Exp Med (2012) 1.15
ATF3 regulates MCMV infection in mice by modulating IFN-gamma expression in natural killer cells. Proc Natl Acad Sci U S A (2008) 1.13
Systems analysis identifies an essential role for SHANK-associated RH domain-interacting protein (SHARPIN) in macrophage Toll-like receptor 2 (TLR2) responses. Proc Natl Acad Sci U S A (2011) 1.13
A microfluidic device for multiplexed protein detection in nano-liter volumes. Anal Biochem (2008) 1.12
The Innate Immune Database (IIDB). BMC Immunol (2008) 1.11
Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infect Immun (2003) 1.11
miR-451 regulates dendritic cell cytokine responses to influenza infection. J Immunol (2012) 1.08
Leishmania major activates IL-1 alpha expression in macrophages through a MyD88-dependent pathway. Microbes Infect (2002) 1.07
Simvastatin augments lipopolysaccharide-induced proinflammatory responses in macrophages by differential regulation of the c-Fos and c-Jun transcription factors. J Immunol (2004) 1.06
Gangliosides act as co-receptors for Salmonella enteritidis FliC and promote FliC induction of human beta-defensin-2 expression in Caco-2 cells. J Biol Chem (2004) 1.03
Activation of the NLRP3 inflammasome by intracellular poly I:C. FEBS Lett (2010) 1.02
Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women. PLoS One (2009) 1.00
Elevated cyclic AMP and PDE4 inhibition induce chemokine expression in human monocyte-derived macrophages. Proc Natl Acad Sci U S A (2009) 1.00
Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling. J Clin Invest (2015) 0.99
Generation of a Listeria vaccine strain by enhanced caspase-1 activation. Eur J Immunol (2011) 0.99
A systems biology approach to understanding atherosclerosis. EMBO Mol Med (2010) 0.97
Host susceptibility and clinical outcomes in toll-like receptor 5-deficient patients with typhoid fever in Vietnam. J Infect Dis (2005) 0.96
Characterizing the connectivity of poly-ubiquitin chains by selected reaction monitoring mass spectrometry. Mol Biosyst (2010) 0.94
Control of parasitophorous vacuole expansion by LYST/Beige restricts the intracellular growth of Leishmania amazonensis. PLoS Pathog (2008) 0.94
The innate immune response to Salmonella enterica serovar Typhimurium by macrophages is dependent on TREM2-DAP12. Infect Immun (2008) 0.93
A key role for ATF3 in regulating mast cell survival and mediator release. Blood (2010) 0.92
Differential host response, rather than early viral replication efficiency, correlates with pathogenicity caused by influenza viruses. PLoS One (2013) 0.91
Characterization of innate responses to influenza virus infection in a novel lung type I epithelial cell model. J Gen Virol (2013) 0.91
A systems view of host defense. Nat Biotechnol (2009) 0.91
The toll-like receptor signaling molecule Myd88 contributes to pancreatic beta-cell homeostasis in response to injury. PLoS One (2009) 0.90
Inhibitory receptor paired Ig-like receptor B is exploited by Staphylococcus aureus for virulence. J Immunol (2012) 0.89
Age-dependent signature of metallothionein expression in primary CD4 T cell responses is due to sustained zinc signaling. Rejuvenation Res (2008) 0.89
Systems-level analysis of innate immunity. Annu Rev Immunol (2014) 0.88
Cutting edge: microRNA regulation of macrophage fusion into multinucleated giant cells. J Immunol (2012) 0.86
Hyper-IgE syndrome is not associated with defects in several candidate toll-like receptor pathway genes. Hum Immunol (2005) 0.86
Systems approaches to dissecting immunity. Curr Top Microbiol Immunol (2013) 0.82
Amphiphysin IIm is required for survival of Chlamydia pneumoniae in macrophages. J Exp Med (2004) 0.81
ADITEC: joining forces for next-generation vaccines. Sci Transl Med (2012) 0.81
Corrigendum: Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature (2015) 0.81
Overcoming limitations in the systems vaccinology approach: a pathway for accelerated HIV vaccine development. Curr Opin HIV AIDS (2012) 0.80
Editorial overview. System immunology. Semin Immunol (2013) 0.77
Phagocytic cells. Immunol Rev (2007) 0.77
Alan Aderem: from molecules to megabytes. Interviewed by Nicole LeBrasseur. J Cell Biol (2008) 0.75
Vaccines. Editorial overview. Curr Opin Immunol (2012) 0.75
Alan Aderem. Interview with Asher Mullard. Nat Rev Drug Discov (2011) 0.75